Drugs and Biologicals: contracts expiring in the next 24 months
Full award history for this category →
Contracts ending in 24 months
25
$198,138,894
Ending in the next 6 months
18
$108,829,382
Ending in 6–12 months
0
$0
Incumbent suppliers
17
What the numbers say
- The largest incumbent, Emergent BioSolutions Canada Inc., holds $51,028,589 of the expiring value (26% of the total).
- $108,829,382 of the value ends within 6 months; $0 more ends in months 7–12.
- $84,466,705 (43%) was originally awarded non-competitively — those renewals may or may not be competed.
Value ending per quarter
Quarter · value · number of contracts
2027-Q1$108,829,38218
2028-Q1$88,912,8826
2028-Q2$396,6301
Top incumbents with expiring contracts
| Supplier | Contracts | Value | First end date |
|---|---|---|---|
| Emergent BioSolutions Canada Inc. | 2 | $51,028,589 | 2027-03-31 |
| Seqirus Canada Inc | 1 | $47,139,750 | 2028-03-31 |
| ELUSYS THERAPEUTICS INC | 1 | $45,712,664 | 2027-03-31 |
| EMERGENT BIOSOLUTIONS INC | 1 | $34,175,344 | 2028-03-31 |
| Emergent BioDefense Operations Lansing LLC | 2 | $7,168,254 | 2027-03-31 |
| HEYL Chem.-pharm. Fabrik GmbH & Co. KG | 1 | $4,466,530 | 2028-03-31 |
| Methapharm Inc. | 1 | $2,835,000 | 2028-03-31 |
| EMERGENT BIOSOLUTIONS | 2 | $1,826,794 | 2027-03-31 |
| SANDOZ CANADA INC. | 1 | $1,283,583 | 2027-03-31 |
| Dr. Reddy's Laboratories Canada Inc | 1 | $832,960 | 2027-03-31 |
| SANOFI PASTEUR LIMITED | 2 | $400,682 | 2027-03-31 |
| GLAXOSMITHKLINE | 2 | $335,060 | 2027-03-31 |
| Indivior UK Ltd | 4 | $321,750 | 2027-03-31 |
| Rafa Laboratories Ltd | 1 | $246,500 | 2027-03-31 |
| Pfizer Canada Inc | 1 | $239,161 | 2027-03-31 |
Expiring by department
| Department | Contracts | Value |
|---|---|---|
| Public Health Agency of Canada | 7 | $130,971,096 |
| National Defence | 7 | $65,744,873 |
| Correctional Service of Canada | 10 | $1,396,540 |
| Health Canada | 1 | $26,386 |
Largest contracts ending in the next 12 months
| End date | Description | Incumbent | Department | Value | Procedure | Source |
|---|---|---|---|---|---|---|
| 2027-03-31 | Pharmaceutical and other medicinal products | ELUSYS THERAPEUTICS INC | Public Health Agency of Canada | $45,712,664 | Non-competitive | Proactive disclosure |
| 2027-03-31 | Pharmaceutical and other medicinal products | Emergent BioSolutions Canada Inc. | National Defence | $44,758,560 | Advance contract award notice | Proactive disclosure |
| 2027-03-31 | Pharmaceutical and other medicinal products | Emergent BioSolutions Canada Inc. | National Defence | $6,270,029 | Advance contract award notice | Proactive disclosure |
| 2027-03-31 | Pharmaceutical and other medicinal products | Emergent BioDefense Operations Lansing LLC | National Defence | $6,119,214 | Advance contract award notice | Proactive disclosure |
| 2027-03-31 | Pharmaceutical and other medicinal products | EMERGENT BIOSOLUTIONS | Public Health Agency of Canada | $1,430,164 | Competitive | Proactive disclosure |
| 2027-03-31 | Pharmaceutical and other medicinal products | SANDOZ CANADA INC. | Public Health Agency of Canada | $1,283,583 | Open bidding | Proactive disclosure |
| 2027-03-31 | Drugs and Biologicals | Emergent BioDefense Operations Lansing LLC | National Defence | $1,049,040 | Advance contract award notice | Proactive disclosure |
| 2027-03-31 | Pharmaceutical and other medicinal products | Dr. Reddy's Laboratories Canada Inc | Public Health Agency of Canada | $832,960 | Non-competitive | Proactive disclosure |
| 2027-03-31 | Pharmaceutical and other medicinal products | Rafa Laboratories Ltd | National Defence | $246,500 | Advance contract award notice | Proactive disclosure |
| 2027-03-31 | Pharmaceutical and Other Medicinal Products | Pfizer Canada Inc | Correctional Service of Canada | $239,161 | Non-competitive | Proactive disclosure |
| 2027-03-31 | Pharmaceutical and Other Medicinal Products | SANOFI PASTEUR LIMITED | Correctional Service of Canada | $236,628 | Non-competitive | Proactive disclosure |
| 2027-03-31 | Pharmaceutical and Other Medicinal Products | SANOFI PASTEUR LIMITED | Correctional Service of Canada | $164,054 | Advance contract award notice | Proactive disclosure |
| 2027-03-31 | Pharmaceutical and Other Medicinal Products | GLAXOSMITHKLINE | Correctional Service of Canada | $138,690 | Non-competitive | Proactive disclosure |
| 2027-03-31 | Pharmaceutical and Other Medicinal Products | Indivior UK Ltd | Correctional Service of Canada | $96,250 | Advance contract award notice | Proactive disclosure |
| 2027-03-31 | Pharmaceutical and Other Medicinal Products | Indivior UK Ltd | Correctional Service of Canada | $82,500 | Advance contract award notice | Proactive disclosure |
| 2027-03-31 | Pharmaceutical and Other Medicinal Products | Indivior UK Ltd | Correctional Service of Canada | $74,250 | Advance contract award notice | Proactive disclosure |
| 2027-03-31 | Pharmaceutical and Other Medicinal Products | Indivior UK Ltd | Correctional Service of Canada | $68,750 | Advance contract award notice | Proactive disclosure |
| 2027-03-31 | Pharmaceutical and other medicinal products | SANOFI VACCINES CANADA LTD. | Health Canada | $26,386 | Open bidding | Proactive disclosure |
Method and sources
End dates come from the Government of Canada's proactive disclosure of contracts over $10,000 (delivery or contract-end date) and from CanadaBuys award notices (contract end date), published under the Open Government Licence – Canada.
An end date is not a re-tender announcement: the buyer may extend, exercise an option, use a standing offer, or stop buying. Treat each row as a lead to verify. Amendment rows that repeat a contract's running total are collapsed, so totals are approximate.
Refreshed daily. Last refresh: 2026-10-16 · Proactive disclosure dataset · CanadaBuys award notices